Degron Therapeutics
PrivateLast Round
Series A
Extension
May 14, 2026
Total Funding Raised
$102M
Momentum Score
50 /100
Company Overview
Degron Therapeutics is a biotechnology company developing a new class of small-molecule medicines that target previously undruggable targets.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Degron Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Degron Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | May 14, 2026 | ||||
| Series A Extension | May 14, 2024 | ||||
| Series A | Jun 9, 2022 |
Key People
Founding team and executive leadership
Degron Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DYEE Capital | Series A |
| Co-Win Ventures | Series A |
| YuanBio Venture Capital | Series A |
| GF Xinde Investment Management | Series A Extension |
| Lapam Capital | Series A Extension |
| Zhongke Chuangxing | Series A Extension |
| Shenzhen Dachen Caizhi Venture Capital Management | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 14, 2026
$40M round led by Lapam Capital.
- May 14, 2024
$40M round led by Lapam Capital.
Degron Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Degron Therapeutics's valuation, stock price, and market status.
